Additional eculizumab dose and tacrolimus discontinuation for treatment of COVID-19 in a kidney transplant recipient with aHUS
Ther Apher Dial
.
2022 Feb;26(1):250-251.
doi: 10.1111/1744-9987.13710.
Epub 2021 Jul 24.
Authors
Nikolina Bašić-Jukić
1
,
Armin Atić
1
Affiliation
1
Department of Nephrology, Arterial hypertension, Dialysis and Transplantation, Clinical Hospital centre Zagreb, Zagreb, Croatia.
PMID:
34272820
PMCID:
PMC8420508
DOI:
10.1111/1744-9987.13710
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized
COVID-19*
Humans
Kidney Transplantation*
SARS-CoV-2
Tacrolimus
Substances
Antibodies, Monoclonal, Humanized
eculizumab
Tacrolimus